Journal article Published 2013

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab.

Magdalena Hudcová, M.E. Dujaric, J. Lehmann-Che, V. Scott, O. Tembo, B. Asselain, J.Y. Pierga, M. Marty, P.De Cremoux, F. Spyratos, I. Bieche

British Journal of Cancer 108(9), 1807-1809 (2013)

View on PubMed Cite

2013 Year
23612454 PMID

Cite this publication

ČÍŽKOVÁ, M., M. DUJARIC, J. LEHMANN-CHE, V. SCOTT, O. TEMBO, B. ASSELAIN, J. PIERGA, M. MARTY, P. CREMOUX, F. SPYRATOS, I. BIECHE: Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab. British Journal of Cancer. 2013, 108(9), 1807-1809, ISSN: 0007-0920, PMID: 23612454.

Cite this publication

Details